NFKB1 and rheumatoid arthritis: Interestingly, only TEO reduced CRP levels in the RA model, while CURC was the sole metabolite preventing cytokine-mediated NF-κB activation and ICAM induction in vascular endothelial cells, suggesting possible benefits in CV-risk reduction using turmeric metabolites in combination.